Cite
HARVARD Citation
Desai, P. et al. (2021). Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Journal of clinical oncology. 39 (29), pp. 3261-3272. [Online].